Good morning. I welcome everyone to the third meeting of the Public Petitions Committee in 2021. This meeting is being held virtually. I will be participating via audio only, but the rest of the members will be visible.
The only item on our agenda today is consideration of continued petitions. The first petition is PE1517, which was lodged by Elaine Holmes and Olive McIlroy on behalf of the Scottish mesh survivors hear our voice campaign.
I welcome Jackson Carlaw and Neil Findlay. I understand that John Scott, who has had an interest in the petition in the past, may be joining us, but he has not joined us so far.
The petition calls on the Scottish Government to suspend the use of polypropylene transvaginal mesh procedures; to initiate a public inquiry and/or comprehensive independent research to evaluate the safety of mesh devices using all evidence available, including evidence from around the world; to introduce mandatory reporting of all adverse incidents by health professionals; to set up a Scottish transvaginal mesh implant register, with a view to linking it up with national and international registers; to introduce fully informed consent uniformly throughout Scotland’s health boards; and to write to the Medicines and Healthcare products Regulatory Agency, asking it to reclassify TVM devices with heightened alert status to reflect on-going concerns worldwide.
The petition was last considered in October 2020, when we took evidence from Dr Dionysios Veronikis. Since that evidence session, we have received submissions from the Cabinet Secretary for Health and Sport, the chief medical officer, the Royal College of Obstetricians and Gynaecologists, and the petitioners. In their submissions, the cabinet secretary and the chief medical officer highlight actions that the Scottish Government is taking to work with mesh-injured women to improve the national specialist service; establish close working relationships with the equivalent services that are being developed by NHS England; consider what further steps can be taken to provide additional options for patients, including referral outside the national health service; and take a proposal to the United Kingdom medical education reference group, which is the first step in the current process for submitting proposals for a General Medical Council-regulated credential with respect to mesh removal surgery.
In their submission, the petitioners reiterate that they do not believe that there is a safe and proven treatment route in Scotland. As such, they are calling on the Scottish Government to fund women so that they can travel to the United States to be treated by a surgeon they trust and choose, if that is their wish. The petitioners also call for the Scottish Government to refund the small number of women who have already paid life savings to attend surgeons in the United States.
Since the publication of our papers, we have received a submission from Dr Wael Agur, which notes that he has helped to develop the West of Scotland pelvic mesh complications pathway. He describes that care pathway as the most comprehensive for mesh-injured women in Scotland and states that it is being considered by Government officials for national use. He also states that, for most deeply embedded mesh devices, other than vertical retropubic mesh devices, he does not expect members of the mesh multidisciplinary team to be confident that the surgical skills are adequate for total device removal, in a safe and effective manner, in Scotland. He believes that, until the service builds expertise and trust in this area, a funded out-of-country referral pathway to the US or to England should be put in place for women who wish to use it.
We have looked at the petition previously in some detail. I will invite our visitor MSPs to make their contributions before I ask committee members to reflect on what we should do with the petition.
